I now have everything needed for a comprehensive, exam-ready answer. Let me compile it all.
𧬠LYSOSOMAL STORAGE DISORDERS (LSD)
Complete Biochemistry Exam Notes - Easy Language
Sources: Robbins & Kumar Basic Pathology, Ganong's Medical Physiology, Histology Text & Atlas (Mescher)
PART 1: WHAT IS A LYSOSOMAL STORAGE DISORDER?
First - What does a Lysosome do?
Think of a lysosome as the "dustbin" or "recycling factory" of the cell.
- It contains hydrolytic (digestive) enzymes that break down complex molecules
- These molecules include: sphingolipids, glycoproteins, mucopolysaccharides (glycosaminoglycans), glycogen
- After breakdown, the small soluble end products are recycled back to the cell
The enzymes work best at ACIDIC pH (inside the lysosome) - this is a safety feature. If a lysosome bursts, the enzymes don't work well at the neutral pH of the cytoplasm, so they can't damage the cell.
What happens in LSD?
One enzyme is missing β its substrate cannot be broken down β substrate piles up inside lysosomes β lysosomes swell β cell stops working β organ fails
Normal: Complex substrate β Enzyme A β Enzyme B β Enzyme C β Small soluble products β
In LSD: Complex substrate β Enzyme A β [ENZYME B MISSING] β SUBSTRATE PILES UP β
Two extra problems happen because of this:
- Autophagy fails - the cell can't clean up its own dead organelles
- Defective mitochondria pile up β generate free radicals β cause apoptosis (cell death)
PART 2: GENERAL FEATURES OF ALL LSDs
These features are common to almost all lysosomal storage diseases:
| Feature | Explanation |
|---|
| Autosomal recessive | Both parents must carry the defective gene |
| Affects infants and young children | Children appear normal at birth, then deteriorate |
| Hepatosplenomegaly | Liver and spleen enlarge (full of storage cells) |
| CNS involvement | Brain neurons damaged β mental retardation, regression |
| Progressive course | Gets worse over time |
| Combined incidence ~1 in 2500 live births | Rare individually, but significant together |
PART 3: CLASSIFICATION OF LSDs
LSDs are grouped by what type of molecule accumulates:
| Category | What accumulates | Examples |
|---|
| Sphingolipidoses | Sphingolipids | Gaucher, Tay-Sachs, Niemann-Pick, Krabbe, Fabry |
| Mucopolysaccharidoses (MPS) | Glycosaminoglycans (GAGs) | Hurler (MPS I), Hunter (MPS II) |
| Glycogenosis | Glycogen | Pompe disease |
| Mucolipidoses | Mucopolysaccharide + glycolipid | I-cell disease |
| Others | Cholesterol, triglycerides | Wolman disease |
PART 4: INDIVIDUAL DISEASES - DETAILED
π΄ 1. TAY-SACHS DISEASE (GM2 Gangliosidosis)
Memory hook: "TAY = Tiny Ashkenazi Youth destroyed"
| Feature | Details |
|---|
| Enzyme missing | Hexosaminidase A (alpha subunit) |
| What accumulates | GM2 ganglioside (in neurons) |
| Inheritance | Autosomal recessive |
| Affected population | Ashkenazi Jews (1 in 30 are carriers!) |
| Onset | 3-6 months of age (motor weakness first) |
Clinical features:
- Motor weakness starting 3-6 months
- Progressive mental retardation and blindness
- "Cherry-red spot" on the macula of the retina (CLASSIC EXAM SIGN!)
- Why? Ganglion cells around the macula swell and turn pale β only the central macula (which has fewer ganglion cells) keeps its normal red colour β looks like a cherry
- Neurons show "onion-skin" whorled membranous configurations under electron microscopy
- Death within 2-3 years
Diagnosis: Measure hexosaminidase A in serum or leukocytes
Treatment: None curative - supportive only
π 2. NIEMANN-PICK DISEASE
Memory hook: "Niemann = No sphingomyelinase = Neurons Perish"
Type A (Severe - infantile)
| Feature | Details |
|---|
| Enzyme missing | Sphingomyelinase |
| What accumulates | Sphingomyelin |
| Inheritance | Autosomal recessive |
| Affected population | Ashkenazi Jews (like Tay-Sachs) |
Features:
- Massive hepatosplenomegaly
- Foam cells (macrophages stuffed with sphingomyelin) in liver, spleen, bone marrow
- Electron microscopy: "Zebra bodies" (concentric lamellar myelin figures) in neurons
- Severe CNS deterioration β death within first 3 years
- Cherry-red spot on retina (similar to Tay-Sachs)
Type B (Mild - visceral only)
- Some residual sphingomyelinase activity
- Organomegaly but NO neurologic involvement
- Compatible with longer survival
Type C (Distinct - cholesterol transport defect!)
- NOT an enzyme deficiency - it's a cholesterol TRANSPORT defect
- Genes affected: NPC1 and NPC2 (cholesterol transporters)
- Cholesterol + GM1/GM2 gangliosides accumulate
- Features: ataxia, vertical gaze palsy, dystonia, psychomotor regression
- Linked to Alzheimer disease risk
Diagnosis: Sphingomyelinase activity in leukocytes (for Type A/B)
π‘ 3. GAUCHER DISEASE (Most Common LSD!)
Memory hook: "GAUCHEr = Glucocerebrosidase Absent Unequivocally - Causes Hepatosplenomegaly Enormously"
| Feature | Details |
|---|
| Enzyme missing | Glucocerebrosidase (beta-glucocerebrosidase) |
| What accumulates | Glucocerebroside (glucosylceramide) |
| Inheritance | Autosomal recessive |
| Where it accumulates | Mononuclear phagocyte cells (macrophages) in liver, spleen, bone marrow |
Pathological hallmark: "GAUCHER CELLS"
- Enlarged macrophages (up to 100 Β΅m!) stuffed with glucocerebroside
- Cytoplasm looks like "crumpled/wrinkled tissue paper" - classic exam answer!
3 Types:
| Type | CNS involvement? | Clinical features |
|---|
| Type 1 (most common) | None | Hepatosplenomegaly, bone disease, anemia, thrombocytopenia |
| Type 2 (acute neuronopathic) | Severe | Onset <2 years, rapid neurologic decline, death by age 2 |
| Type 3 (chronic neuronopathic) | Mild | Slower neurologic decline, hepatosplenomegaly |
Special connections:
- Gaucher carrier state is a major genetic risk factor for Parkinson disease
- Virtually all Gaucher disease patients eventually develop Parkinson disease
Treatment: Enzyme Replacement Therapy (ERT) - imiglucerase (Cerezyme) - most successful ERT for any LSD
π’ 4. FABRY DISEASE
Memory hook: "FABRY = Ξ±-GAlactosidase Deficiency β acRostic pain + angliokeratomas + kYdney failure"
| Feature | Details |
|---|
| Enzyme missing | Ξ±-galactosidase A |
| What accumulates | Ceramide trihexoside (globotriaosylceramide) |
| Inheritance | X-LINKED recessive (only LSD that is X-linked!) |
| Affected population | Males primarily |
Clinical features:
- Angiokeratomas (dark red skin lesions on buttocks, genitalia)
- Acroparesthesias - burning pain in hands and feet
- Corneal opacities (clouding of cornea)
- Renal failure (major cause of death)
- Cardiomyopathy (heart disease)
π΅ 5. POMPE DISEASE (Glycogen Storage Disease Type II)
Memory hook: "POMPE = acid maltase missing β PUMP of the heart fails"
| Feature | Details |
|---|
| Enzyme missing | Acid alpha-1,4-glucosidase (acid maltase) |
| What accumulates | Glycogen (in lysosomes!) |
| Inheritance | Autosomal recessive |
Important point: This is a GLYCOGEN storage disease that is also a lysosomal storage disease because the enzyme is a LYSOSOMAL enzyme!
Clinical features (infantile type):
- Massive cardiomegaly (heart full of glycogen β heart failure)
- Muscle hypotonia (floppy baby)
- Hepatomegaly
- Death from cardiorespiratory failure before age 2
Adult type: Only skeletal muscle involvement β chronic myopathy
π£ 6. HURLER SYNDROME (MPS Type I)
Memory hook: "HURLER = Horrible face + ugly bones + no brain"
| Feature | Details |
|---|
| Enzyme missing | Ξ±-L-iduronidase |
| What accumulates | Dermatan sulfate + Heparan sulfate (glycosaminoglycans) |
| Inheritance | Autosomal recessive |
| MPS Type | MPS I |
Clinical features ("gargoyle face"):
- Coarse facial features (thick lips, flat nose, wide-spaced eyes)
- Short stature, skeletal deformities
- Corneal clouding
- Mental retardation
- Cardiac defects, hearing loss
- Hepatosplenomegaly
- Stiff joints
βͺ 7. HUNTER SYNDROME (MPS Type II)
Memory hook: "HUNTER = X-linked (boys go HUNTING)"
| Feature | Details |
|---|
| Enzyme missing | Iduronate sulfatase (iduronosulfate sulfatase) |
| What accumulates | Dermatan sulfate + Heparan sulfate |
| Inheritance | X-LINKED recessive (like Fabry!) |
| MPS Type | MPS II |
Similar to Hurler but:
- Milder than Hurler
- NO corneal clouding (key difference from Hurler!)
- Affects only males
β« 8. KRABBE DISEASE
| Feature | Details |
|---|
| Enzyme missing | Galactosylceramidase |
| What accumulates | Galactocerebroside |
| Key cell | "Globoid cells" - giant multinucleated macrophages in white matter |
| Features | Rapidly progressive, severe neurological deterioration, early death |
π΄ 9. METACHROMATIC LEUKODYSTROPHY
| Feature | Details |
|---|
| Enzyme missing | Arylsulfatase A |
| What accumulates | Sulfatide (cerebroside sulfate) |
| Key feature | Demyelination of white matter (leukodystrophy) |
| Metachromatic | Stored material stains orange-brown with toluidine blue (instead of the expected blue) |
PART 5: QUICK COMPARISON TABLE
| Disease | Enzyme Missing | Accumulates | Key Feature |
|---|
| Tay-Sachs | Hexosaminidase A | GM2 ganglioside | Cherry-red macula, Ashkenazi Jews |
| Niemann-Pick A/B | Sphingomyelinase | Sphingomyelin | Foam cells, zebra bodies |
| Niemann-Pick C | NPC1/NPC2 (transporter) | Cholesterol | Vertical gaze palsy |
| Gaucher | Glucocerebrosidase | Glucocerebroside | Wrinkled tissue paper cells |
| Fabry | Ξ±-Galactosidase A | Ceramide trihexoside | X-linked, kidney failure |
| Pompe | Acid maltase | Glycogen | Cardiomegaly, floppy baby |
| Hurler (MPS I) | Ξ±-L-Iduronidase | Dermatan + Heparan sulfate | Coarse features, corneal clouding |
| Hunter (MPS II) | Iduronate sulfatase | Dermatan + Heparan sulfate | X-linked, NO corneal clouding |
| Krabbe | Galactosylceramidase | Galactocerebroside | Globoid cells |
| MLD | Arylsulfatase A | Sulfatide | Metachromatic staining |
PART 6: TREATMENT APPROACHES
| Treatment | Diseases it works for |
|---|
| Enzyme Replacement Therapy (ERT) | Gaucher (most successful!), Fabry, Pompe, Hurler, Hunter |
| Bone marrow / Stem cell transplant | Some MPS, Krabbe (if caught early) |
| Pharmacologic Chaperone therapy | Fabry, some Gaucher (synthetic chaperones help misfold enzyme fold correctly) |
| Gene therapy | Under research |
| Substrate Reduction Therapy | Gaucher, Niemann-Pick C (reduce substrate production) |
PART 7: DIAGNOSIS OF LSDs
| Method | How |
|---|
| Enzyme assay | Measure specific enzyme activity in leukocytes/fibroblasts |
| Urine metabolites | Spot test for GAGs in urine (MPS), oligosaccharides |
| Molecular/DNA testing | Identify specific gene mutations |
| Newborn screening | Tandem mass spectrometry (MS/MS) - can detect enzyme levels at birth |
| Biopsy + histology | Characteristic storage cells (Gaucher cells, foam cells, globoid cells) |
PART 8: LIGHTNING FAST MEMORY TRICKS π§
- Tay-Sachs = Two copies wrong β Tiny baby, Cherry-Red spot, Ashkenazi Jews
- Gaucher = Gluco + wrinkled Gaucher cells = most Generous response to ERT
- Niemann-Pick = No sphingomyelinase β Neurons Perish + Foam cells
- Fabry = Female carriers (X-linked) β males Fail (kidneys, heart)
- Pompe = Pump fails β cardiomegaly (acid Maltase missing)
- Hurler = Horrible face (gargoyle), Hepato-splenomegaly, Hard corneas (clouding)
- Hunter = Hunting with X (X-linked), No corneal clouding - Hunters need clear eyes!
PART 9: WHAT DISTINGUISHES LSDs FROM EACH OTHER (Exam favourite!)
| Question | Answer |
|---|
| Only X-linked LSD (common ones) | Fabry and Hunter syndrome |
| Cherry-red spot | Tay-Sachs, Niemann-Pick A |
| "Wrinkled tissue paper" cells | Gaucher disease |
| "Foam cells / Zebra bodies" | Niemann-Pick A |
| "Globoid cells" | Krabbe disease |
| Metachromatic staining | Metachromatic Leukodystrophy |
| Cardiomegaly in infant | Pompe disease |
| Gargoyle face + corneal clouding | Hurler syndrome |
| Ashkenazi Jews (2 diseases) | Tay-Sachs + Niemann-Pick A/B |
| Connected to Parkinson disease | Gaucher disease |
| Connected to Alzheimer disease | Niemann-Pick C |
| Most common LSD in children | Gaucher disease |
| Lipid transport defect (not enzyme) | Niemann-Pick C |
You've got this for tomorrow! π
Key formula to remember: ONE enzyme missing β ONE substrate piles up β Lysosomes swell β Cell dies β Organ fails
All LSDs are autosomal recessive EXCEPT Fabry and Hunter which are X-linked recessive.